Accessibility Menu
 

The Best of 2012 #6: Celsion

Celsion's platform targeting cancer cells more specifically has the company up 341% for the year, making it #6 on our list of the very best in health-care stocks of 2012.

By Dave Williamson and Max Macaluso Dec 13, 2012 at 5:27PM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.